bms 180448 has been researched along with alinidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lodge, NJ; Smith, MA | 1 |
| Carroll, WA; Coghlan, MJ; Gopalakrishnan, M | 1 |
1 review(s) available for bms 180448 and alinidine
| Article | Year |
|---|---|
Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress.
Topics: Adenosine Triphosphate; Angina Pectoris; Arrhythmias, Cardiac; Asthma; Calcium; Ion Channel Gating; Myocardial Ischemia; Potassium Channel Blockers; Potassium Channels; Urinary Incontinence | 2001 |
1 other study(ies) available for bms 180448 and alinidine
| Article | Year |
|---|---|
The novel cardioprotective agent BMS-180448 activates a potassium conductance in cardiac and vascular smooth muscle.
Topics: Animals; Aorta, Thoracic; Benzopyrans; Cardiotonic Agents; Cardiovascular Agents; Cells, Cultured; Clonidine; Glyburide; Guanidines; Guinea Pigs; Heart Ventricles; Male; Muscle, Smooth, Vascular; Myocardium; Patch-Clamp Techniques; Potassium Channels; Rabbits; Rubidium Radioisotopes | 1996 |